These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19553789)

  • 1. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
    Busch T
    Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for combination therapy in age-related macular degeneration.
    Spaide RF
    Retina; 2009 Jun; 29(6 Suppl):S5-7. PubMed ID: 19553803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS
    Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
    Hohman TC
    Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G
    Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy using the small interfering RNA bevasiranib.
    Singerman L
    Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ziemssen F; Heiduschka P; Schraermeyer U;
    Retina; 2007 Oct; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination angiostatic therapies: current status.
    Peyman GA; Fiscella R; Conway M
    Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
    Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy in the anti-VEGF era.
    Fine HF
    Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting angiogenesis in retinoblastoma.
    Apte RS; Harbour JW
    Ophthalmic Res; 2007; 39(4):188-90. PubMed ID: 17556838
    [No Abstract]   [Full Text] [Related]  

  • 16. Bevacizumab: a new way of doing business?
    Canning C; Lotery A
    Eye (Lond); 2006 Sep; 20(9):985-7. PubMed ID: 16858443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment options for retinal angiomatous proliferans (RAP).
    Gupta B; Jyothi S; Sivaprasad S
    Br J Ophthalmol; 2010 Jun; 94(6):672-7. PubMed ID: 19897475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].
    Holz FG; Miller DW
    Ophthalmologe; 2003 Feb; 100(2):97-103. PubMed ID: 12589452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and age-related macular degeneration.
    McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
    Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.